BAVENCIO 20 mg/mL
avelumab · INJECTION, SOLUTION, CONCENTRATE · EMD Serono, Inc.
No Recall History
Plain English
BAVENCIO is a injection, solution, concentrate containing avelumab at 20 mg/mL, taken intravenous. Manufactured by EMD Serono, Inc..
Key Facts
- Brand Name
- BAVENCIO
- Generic Name
- avelumab
- NDC Code (Product)
44087-3535- Manufacturer
- EMD Serono, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761049
- Drug Class
- Programmed Death Ligand-1 Blocker [EPC]
- Marketing Start
- 03/23/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is BAVENCIO used for?
BAVENCIO contains avelumab. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is BAVENCIO a controlled substance?
BAVENCIO is not classified as a controlled substance by the DEA.
What is the generic name for BAVENCIO?
The generic name for BAVENCIO is avelumab. There are no other listed brand versions of avelumab.
What is the NDC code for BAVENCIO 20 mg/mL?
The NDC (National Drug Code) for BAVENCIO 20 mg/mL is 44087-3535, listed by EMD Serono, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)